Influenza-like-illness and clinically diagnosed flu: disease burden, costs and quality of life for patients seeking ambulatory care or no professional care at all.
Identifieur interne : 000037 ( Main/Exploration ); précédent : 000036; suivant : 000038Influenza-like-illness and clinically diagnosed flu: disease burden, costs and quality of life for patients seeking ambulatory care or no professional care at all.
Auteurs : Joke Bilcke [Belgique] ; Samuel Coenen [Belgique] ; Philippe Beutels [Australie]Source :
- PloS one [ 1932-6203 ] ; 2014.
Descripteurs français
- KwdFr :
- Acceptation des soins par le patient, Adolescent, Adulte, Adulte d'âge moyen, Belgique, Coût de la maladie, Enfant, Enquêtes et questionnaires, Femelle, Grippe humaine (diagnostic), Grippe humaine (traitement médicamenteux), Grippe humaine (virologie), Humains, Jeune adulte, Mâle, Qualité de vie, Soins ambulatoires (), Sujet âgé, Vaccination, Vaccins antigrippaux (immunologie).
- MESH :
- diagnostic : Grippe humaine.
- immunologie : Vaccins antigrippaux.
- traitement médicamenteux : Grippe humaine.
- virologie : Grippe humaine.
- Acceptation des soins par le patient, Adolescent, Adulte, Adulte d'âge moyen, Belgique, Coût de la maladie, Enfant, Enquêtes et questionnaires, Femelle, Humains, Jeune adulte, Mâle, Qualité de vie, Soins ambulatoires, Sujet âgé, Vaccination.
English descriptors
- KwdEn :
- Adolescent, Adult, Aged, Ambulatory Care (statistics & numerical data), Belgium, Child, Cost of Illness, Female, Humans, Influenza Vaccines (immunology), Influenza, Human (diagnosis), Influenza, Human (drug therapy), Influenza, Human (virology), Male, Middle Aged, Patient Acceptance of Health Care, Quality of Life, Surveys and Questionnaires, Vaccination, Young Adult.
- MESH :
- chemical , immunology : Influenza Vaccines.
- diagnosis : Influenza, Human.
- drug therapy : Influenza, Human.
- statistics & numerical data : Ambulatory Care.
- virology : Influenza, Human.
- Adolescent, Adult, Aged, Belgium, Child, Cost of Illness, Female, Humans, Male, Middle Aged, Patient Acceptance of Health Care, Quality of Life, Surveys and Questionnaires, Vaccination, Young Adult.
Abstract
This is one of the first studies to (1) describe the out-of-hospital burden of influenza-like-illness (ILI) and clinically diagnosed flu, also for patients not seeking professional medical care, (2) assess influential background characteristics, and (3) formally compare the burden of ILI in patients with and without a clinical diagnosis of flu. A general population sample with recent ILI experience was recruited during the 2011-2012 influenza season in Belgium. Half of the 2250 respondents sought professional medical care, reported more symptoms (especially more often fever), a longer duration of illness, more use of medication (especially antibiotics) and a higher direct medical cost than patients not seeking medical care. The disease and economic burden were similar for ambulatory ILI patients, irrespective of whether they received a clinical diagnosis of flu. On average, they experienced 5-6 symptoms over a 6-day period; required 1.6 physician visits and 86-91% took medication. An average episode amounted to €51-€53 in direct medical costs, 4 days of absence from work or school and the loss of 0.005 quality-adjusted life-years. Underlying illness led to greater costs and lower quality-of-life. The costs of ILI patients with clinically diagnosed flu tended to increase, while those of ILI patients without clinically diagnosed flu tended to decrease with age. Recently vaccinated persons experienced lower costs and a higher quality-of-life, but this was only the case for patients not seeking professional medical care. This information can be used directly to evaluate the implementation of cost-effective prevention and control measures for influenza. In particular to inform the evaluation of more widespread seasonal influenza vaccination, including in children, which is currently considered by many countries.
DOI: 10.1371/journal.pone.0102634
PubMed: 25032688
Affiliations:
- Australie, Belgique
- Nouvelle-Galles du Sud, Province d'Anvers, Région flamande
- Anvers, Sydney
- Université d'Anvers
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Influenza-like-illness and clinically diagnosed flu: disease burden, costs and quality of life for patients seeking ambulatory care or no professional care at all.</title><author><name sortKey="Bilcke, Joke" sort="Bilcke, Joke" uniqKey="Bilcke J" first="Joke" last="Bilcke">Joke Bilcke</name><affiliation wicri:level="4"><nlm:affiliation>Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute (VAXINFECTIO) WHO collaborating Centre, Faculty of Medicine & Health Sciences, University of Antwerp, Antwerp, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute (VAXINFECTIO) WHO collaborating Centre, Faculty of Medicine & Health Sciences, University of Antwerp, Antwerp</wicri:regionArea><orgName type="university">Université d'Anvers</orgName><placeName><settlement type="city">Anvers</settlement><region>Région flamande</region><region type="district" nuts="2">Province d'Anvers</region></placeName></affiliation></author><author><name sortKey="Coenen, Samuel" sort="Coenen, Samuel" uniqKey="Coenen S" first="Samuel" last="Coenen">Samuel Coenen</name><affiliation wicri:level="4"><nlm:affiliation>Centre for General Practice, Primary and Interdisciplinary Care (ELIZA), Faculty of Medicine & Health Sciences, University of Antwerp, Antwerp, Belgium; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO) WHO collaborating Centre, Faculty of Medicine & Health Sciences, University of Antwerp, Antwerp, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Centre for General Practice, Primary and Interdisciplinary Care (ELIZA), Faculty of Medicine & Health Sciences, University of Antwerp, Antwerp, Belgium; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO) WHO collaborating Centre, Faculty of Medicine & Health Sciences, University of Antwerp, Antwerp</wicri:regionArea><orgName type="university">Université d'Anvers</orgName><placeName><settlement type="city">Anvers</settlement><region>Région flamande</region><region type="district" nuts="2">Province d'Anvers</region></placeName></affiliation></author><author><name sortKey="Beutels, Philippe" sort="Beutels, Philippe" uniqKey="Beutels P" first="Philippe" last="Beutels">Philippe Beutels</name><affiliation wicri:level="4"><nlm:affiliation>Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute (VAXINFECTIO) WHO collaborating Centre, Faculty of Medicine & Health Sciences, University of Antwerp, Antwerp, Belgium; School of Public Health and Community Medicine, Sydney, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute (VAXINFECTIO) WHO collaborating Centre, Faculty of Medicine & Health Sciences, University of Antwerp, Antwerp, Belgium; School of Public Health and Community Medicine, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region><settlement type="city">Anvers</settlement></placeName><orgName type="university">Université d'Anvers</orgName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:25032688</idno><idno type="pmid">25032688</idno><idno type="doi">10.1371/journal.pone.0102634</idno><idno type="wicri:Area/Main/Corpus">000037</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000037</idno><idno type="wicri:Area/Main/Curation">000037</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000037</idno><idno type="wicri:Area/Main/Exploration">000037</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Influenza-like-illness and clinically diagnosed flu: disease burden, costs and quality of life for patients seeking ambulatory care or no professional care at all.</title><author><name sortKey="Bilcke, Joke" sort="Bilcke, Joke" uniqKey="Bilcke J" first="Joke" last="Bilcke">Joke Bilcke</name><affiliation wicri:level="4"><nlm:affiliation>Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute (VAXINFECTIO) WHO collaborating Centre, Faculty of Medicine & Health Sciences, University of Antwerp, Antwerp, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute (VAXINFECTIO) WHO collaborating Centre, Faculty of Medicine & Health Sciences, University of Antwerp, Antwerp</wicri:regionArea><orgName type="university">Université d'Anvers</orgName><placeName><settlement type="city">Anvers</settlement><region>Région flamande</region><region type="district" nuts="2">Province d'Anvers</region></placeName></affiliation></author><author><name sortKey="Coenen, Samuel" sort="Coenen, Samuel" uniqKey="Coenen S" first="Samuel" last="Coenen">Samuel Coenen</name><affiliation wicri:level="4"><nlm:affiliation>Centre for General Practice, Primary and Interdisciplinary Care (ELIZA), Faculty of Medicine & Health Sciences, University of Antwerp, Antwerp, Belgium; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO) WHO collaborating Centre, Faculty of Medicine & Health Sciences, University of Antwerp, Antwerp, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Centre for General Practice, Primary and Interdisciplinary Care (ELIZA), Faculty of Medicine & Health Sciences, University of Antwerp, Antwerp, Belgium; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO) WHO collaborating Centre, Faculty of Medicine & Health Sciences, University of Antwerp, Antwerp</wicri:regionArea><orgName type="university">Université d'Anvers</orgName><placeName><settlement type="city">Anvers</settlement><region>Région flamande</region><region type="district" nuts="2">Province d'Anvers</region></placeName></affiliation></author><author><name sortKey="Beutels, Philippe" sort="Beutels, Philippe" uniqKey="Beutels P" first="Philippe" last="Beutels">Philippe Beutels</name><affiliation wicri:level="4"><nlm:affiliation>Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute (VAXINFECTIO) WHO collaborating Centre, Faculty of Medicine & Health Sciences, University of Antwerp, Antwerp, Belgium; School of Public Health and Community Medicine, Sydney, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute (VAXINFECTIO) WHO collaborating Centre, Faculty of Medicine & Health Sciences, University of Antwerp, Antwerp, Belgium; School of Public Health and Community Medicine, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region><settlement type="city">Anvers</settlement></placeName><orgName type="university">Université d'Anvers</orgName></affiliation></author></analytic><series><title level="j">PloS one</title><idno type="eISSN">1932-6203</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Ambulatory Care (statistics & numerical data)</term><term>Belgium</term><term>Child</term><term>Cost of Illness</term><term>Female</term><term>Humans</term><term>Influenza Vaccines (immunology)</term><term>Influenza, Human (diagnosis)</term><term>Influenza, Human (drug therapy)</term><term>Influenza, Human (virology)</term><term>Male</term><term>Middle Aged</term><term>Patient Acceptance of Health Care</term><term>Quality of Life</term><term>Surveys and Questionnaires</term><term>Vaccination</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Acceptation des soins par le patient</term><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Belgique</term><term>Coût de la maladie</term><term>Enfant</term><term>Enquêtes et questionnaires</term><term>Femelle</term><term>Grippe humaine (diagnostic)</term><term>Grippe humaine (traitement médicamenteux)</term><term>Grippe humaine (virologie)</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Qualité de vie</term><term>Soins ambulatoires ()</term><term>Sujet âgé</term><term>Vaccination</term><term>Vaccins antigrippaux (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Ambulatory Care</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Belgium</term><term>Child</term><term>Cost of Illness</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Patient Acceptance of Health Care</term><term>Quality of Life</term><term>Surveys and Questionnaires</term><term>Vaccination</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Acceptation des soins par le patient</term><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Belgique</term><term>Coût de la maladie</term><term>Enfant</term><term>Enquêtes et questionnaires</term><term>Femelle</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Qualité de vie</term><term>Soins ambulatoires</term><term>Sujet âgé</term><term>Vaccination</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This is one of the first studies to (1) describe the out-of-hospital burden of influenza-like-illness (ILI) and clinically diagnosed flu, also for patients not seeking professional medical care, (2) assess influential background characteristics, and (3) formally compare the burden of ILI in patients with and without a clinical diagnosis of flu. A general population sample with recent ILI experience was recruited during the 2011-2012 influenza season in Belgium. Half of the 2250 respondents sought professional medical care, reported more symptoms (especially more often fever), a longer duration of illness, more use of medication (especially antibiotics) and a higher direct medical cost than patients not seeking medical care. The disease and economic burden were similar for ambulatory ILI patients, irrespective of whether they received a clinical diagnosis of flu. On average, they experienced 5-6 symptoms over a 6-day period; required 1.6 physician visits and 86-91% took medication. An average episode amounted to €51-€53 in direct medical costs, 4 days of absence from work or school and the loss of 0.005 quality-adjusted life-years. Underlying illness led to greater costs and lower quality-of-life. The costs of ILI patients with clinically diagnosed flu tended to increase, while those of ILI patients without clinically diagnosed flu tended to decrease with age. Recently vaccinated persons experienced lower costs and a higher quality-of-life, but this was only the case for patients not seeking professional medical care. This information can be used directly to evaluate the implementation of cost-effective prevention and control measures for influenza. In particular to inform the evaluation of more widespread seasonal influenza vaccination, including in children, which is currently considered by many countries. </div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25032688</PMID><DateCompleted><Year>2015</Year><Month>12</Month><Day>18</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>7</Issue><PubDate><Year>2014</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>Influenza-like-illness and clinically diagnosed flu: disease burden, costs and quality of life for patients seeking ambulatory care or no professional care at all.</ArticleTitle><Pagination><MedlinePgn>e102634</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0102634</ELocationID><Abstract><AbstractText>This is one of the first studies to (1) describe the out-of-hospital burden of influenza-like-illness (ILI) and clinically diagnosed flu, also for patients not seeking professional medical care, (2) assess influential background characteristics, and (3) formally compare the burden of ILI in patients with and without a clinical diagnosis of flu. A general population sample with recent ILI experience was recruited during the 2011-2012 influenza season in Belgium. Half of the 2250 respondents sought professional medical care, reported more symptoms (especially more often fever), a longer duration of illness, more use of medication (especially antibiotics) and a higher direct medical cost than patients not seeking medical care. The disease and economic burden were similar for ambulatory ILI patients, irrespective of whether they received a clinical diagnosis of flu. On average, they experienced 5-6 symptoms over a 6-day period; required 1.6 physician visits and 86-91% took medication. An average episode amounted to €51-€53 in direct medical costs, 4 days of absence from work or school and the loss of 0.005 quality-adjusted life-years. Underlying illness led to greater costs and lower quality-of-life. The costs of ILI patients with clinically diagnosed flu tended to increase, while those of ILI patients without clinically diagnosed flu tended to decrease with age. Recently vaccinated persons experienced lower costs and a higher quality-of-life, but this was only the case for patients not seeking professional medical care. This information can be used directly to evaluate the implementation of cost-effective prevention and control measures for influenza. In particular to inform the evaluation of more widespread seasonal influenza vaccination, including in children, which is currently considered by many countries. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bilcke</LastName><ForeName>Joke</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute (VAXINFECTIO) WHO collaborating Centre, Faculty of Medicine & Health Sciences, University of Antwerp, Antwerp, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coenen</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for General Practice, Primary and Interdisciplinary Care (ELIZA), Faculty of Medicine & Health Sciences, University of Antwerp, Antwerp, Belgium; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO) WHO collaborating Centre, Faculty of Medicine & Health Sciences, University of Antwerp, Antwerp, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beutels</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute (VAXINFECTIO) WHO collaborating Centre, Faculty of Medicine & Health Sciences, University of Antwerp, Antwerp, Belgium; School of Public Health and Community Medicine, Sydney, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000553" MajorTopicYN="N">Ambulatory Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001530" MajorTopicYN="N">Belgium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017281" MajorTopicYN="Y">Cost of Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010342" MajorTopicYN="N">Patient Acceptance of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>01</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>06</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25032688</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0102634</ArticleId><ArticleId IdType="pii">PONE-D-13-52404</ArticleId><ArticleId IdType="pmc">PMC4102549</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Value Health. 2003 Mar-Apr;6(2):116-25</Citation><ArticleIdList><ArticleId IdType="pubmed">12641862</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Infect Dis J. 2003 Oct;22(10 Suppl):S218-22</Citation><ArticleIdList><ArticleId IdType="pubmed">14551479</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Dis Child. 2004 Nov;89(11):1002-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15499051</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Respir Infect. 1992 Mar;7(1):26-37</Citation><ArticleIdList><ArticleId IdType="pubmed">1609165</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2006 Mar;12(3):452-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16704784</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2005 Dec;10(12):241-4</Citation><ArticleIdList><ArticleId IdType="pubmed">16371695</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Infect Dis J. 2007 Feb;26(2):142-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17259877</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2009;338:b2242</Citation><ArticleIdList><ArticleId IdType="pubmed">19549995</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2010 Apr;7(4):e1000256</Citation><ArticleIdList><ArticleId IdType="pubmed">20386727</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Fam Pract. 2011;12:4</Citation><ArticleIdList><ArticleId IdType="pubmed">21306610</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(3):e17030</Citation><ArticleIdList><ArticleId IdType="pubmed">21399678</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect. 2011 May;62(5):379-87</Citation><ArticleIdList><ArticleId IdType="pubmed">21414357</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2012 Jun 13;30(28):4175-81</Citation><ArticleIdList><ArticleId IdType="pubmed">22546332</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Public Health. 2012;12:968</Citation><ArticleIdList><ArticleId IdType="pubmed">23146107</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2013 Jan 30;31(6):927-42</Citation><ArticleIdList><ArticleId IdType="pubmed">23246550</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2013 Feb;13(2):123-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23265995</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013;8(3):e60477</Citation><ArticleIdList><ArticleId IdType="pubmed">23555979</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013;8(4):e60348</Citation><ArticleIdList><ArticleId IdType="pubmed">23565231</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013;8(5):e63788</Citation><ArticleIdList><ArticleId IdType="pubmed">23717485</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoeconomics. 2013 Aug;31(8):693-702</Citation><ArticleIdList><ArticleId IdType="pubmed">23645539</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin Immunother. 2013 Apr;9(4):834-40</Citation><ArticleIdList><ArticleId IdType="pubmed">23357859</ArticleId></ArticleIdList></Reference><Reference><Citation>Influenza Other Respir Viruses. 2013 Nov;7(6):1017-32</Citation><ArticleIdList><ArticleId IdType="pubmed">23210504</ArticleId></ArticleIdList></Reference><Reference><Citation>Influenza Other Respir Viruses. 2013 Nov;7(6):1103-12</Citation><ArticleIdList><ArticleId IdType="pubmed">23829670</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Australie</li><li>Belgique</li></country><region><li>Nouvelle-Galles du Sud</li><li>Province d'Anvers</li><li>Région flamande</li></region><settlement><li>Anvers</li><li>Sydney</li></settlement><orgName><li>Université d'Anvers</li></orgName></list><tree><country name="Belgique"><region name="Région flamande"><name sortKey="Bilcke, Joke" sort="Bilcke, Joke" uniqKey="Bilcke J" first="Joke" last="Bilcke">Joke Bilcke</name></region><name sortKey="Coenen, Samuel" sort="Coenen, Samuel" uniqKey="Coenen S" first="Samuel" last="Coenen">Samuel Coenen</name></country><country name="Australie"><region name="Nouvelle-Galles du Sud"><name sortKey="Beutels, Philippe" sort="Beutels, Philippe" uniqKey="Beutels P" first="Philippe" last="Beutels">Philippe Beutels</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=ExplorPubmed/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000037 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000037 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= *** parameter Area/wikiCode missing ***
|area= ExplorPubmed
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:25032688
|texte= Influenza-like-illness and clinically diagnosed flu: disease burden, costs and quality of life for patients seeking ambulatory care or no professional care at all.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25032688" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a ExplorPubmed
| This area was generated with Dilib version V0.6.35. |  |